According to a recently published report, the Global Pre-menstrual Syndrome Treatment Market is expected to grow at the CAGR of 2.0% during 2016-2024. The global pre-menstrual syndrome treatment market is segmented on the basis of drug type and geography. The report on global pre-menstrual syndrome treatment market forecast 2016-2024 (by drug type and geography) provides a detailed overview and predictive analysis of the market.
Full report available at global pre-menstrual syndrome treatment market 2016 – 2024 (by drug type and geography) report at http://www.briskinsights.com/report/pre-menstrual-syndrome-treatment-market
Pre-menstrual syndrome (PMS) is defined as a condition that affects women at childbearing age and is characterized by symptoms such as bloating, pain, breast tenderness, body pain, fatigue, mood fluctuation, anxiety, etc. where the exact cause of PMS is unknown. According to the American Psychiatric Association, U.S. almost 90% of women of child bearing age experience premenstrual symptoms and less than 10% are diagnosed with premenstrual dysphoric disorder (PMDD). Government and non-government agencies’ campaigns towards elevating the status of female health and education has attributed to significant growth in demand for female hygiene products and also PMS treatment drugs. Further growth in female education and the number of working female population will contribute to the demand for PMS drugs in the region.
Scope of the report
1. Global Pre-menstrual Syndrome Treatment Market, By Drug Type, 2014–2024 ($ Millon)
1.1. Analgesics (pain killers)
1.2. Oral Contraceptive Pills (OCPs)
1.3. Gonadotropin-releasing Hormone (GnRH)
1.5. Ovarian Suppressors
2. Global Pre-menstrual Syndrome Treatment Market, By Geography, 2014-2024 ($ Millon)
2.1. North America
2.3. Asia Pacific
2.4. Latin America (LATAM)
2.5. Middle East and Africa (MEA)
3. Company Profiles
3.1. Alva-Amco Pharmacal Cos., Inc.
3.2. Bayer, Inc.
3.3. Chattem, Inc. (Sanofi)
3.4. DEKK-TEC, Inc.
3.5. G. R. Lane Health Products Ltd
3.6. McNeil Consumer Healthcare
3.7. MetP Pharma AG
3.8. Pherin Pharmaceuticals, Inc.
3.9. Umecrine Mood AB
3.10. Novartis AG
3.11. GlaxoSmithKline Plc
About Us :
Brisk Insights is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities optimize strategies.
Working in a highly dynamic and multi-dimensional business makes decision making complex. Effective business decisions are a result of the synthesis of market information. Our Research and data analysis is an efficient and cost-effective way of providing robust market analysis and can yield highly valuable intelligence relating to consumers, competitors and markets.
Contact Us :
109 Vernon House
Phone : +448081890034 (UK)
Website : http://www.briskinsights.com/